Total Payments
$2,810
2024 Payments
$262.16
Companies
21
Transactions
147
Medicare Patients
1,486
Medicare Billing
$196,771
Payment Breakdown by Category
Food & Beverage$2,810 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,810 | 147 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $849.56 | 49 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $455.24 | 25 | $0 (2024) |
| Amarin Pharma Inc. | $372.10 | 16 | $0 (2022) |
| Lilly USA, LLC | $191.13 | 9 | $0 (2024) |
| Astellas Pharma US Inc | $150.43 | 8 | $0 (2023) |
| Amgen Inc. | $139.30 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $120.41 | 6 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $116.84 | 5 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $84.13 | 4 | $0 (2018) |
| GlaxoSmithKline, LLC. | $71.28 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $262.16 | 12 | Novo Nordisk Inc ($84.77) |
| 2023 | $250.00 | 11 | Novo Nordisk Inc ($87.85) |
| 2022 | $347.95 | 16 | Novo Nordisk Inc ($106.39) |
| 2021 | $475.92 | 23 | Amarin Pharma Inc. ($142.56) |
| 2020 | $237.10 | 13 | Novo Nordisk Inc ($97.35) |
| 2019 | $391.84 | 24 | Novo Nordisk Inc ($137.17) |
| 2018 | $316.48 | 17 | AstraZeneca Pharmaceuticals LP ($117.98) |
| 2017 | $528.63 | 31 | AstraZeneca Pharmaceuticals LP ($148.25) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Inflammation | ||||||
| 09/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $24.35 | General |
| 06/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Obesity | ||||||
| 06/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Inflammation | ||||||
| 06/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Diabetes | ||||||
| 05/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Respiratory | ||||||
| 03/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Inflammation | ||||||
| 03/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Diabetes | ||||||
| 12/12/2023 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Obesity | ||||||
| 11/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Diabetes | ||||||
| 11/02/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Inflammation | ||||||
| 08/17/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Inflammation | ||||||
| 06/16/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Diabetes | ||||||
| 03/27/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Urology | ||||||
| 02/28/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Obesity | ||||||
| 02/23/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Diabetes | ||||||
| 02/13/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/06/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/23/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Diabetes | ||||||
| 09/27/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/07/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 438 | 716 | $72,442 | $53,189 |
| 2022 | 3 | 357 | 638 | $64,423 | $47,557 |
| 2021 | 3 | 352 | 628 | $63,757 | $49,204 |
| 2020 | 3 | 339 | 628 | $62,178 | $46,821 |
Total Patients
1,486
Total Services
2,610
Medicare Billing
$196,771
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 254 | $29,307 | $19,037 | 65.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 136 | 136 | $17,131 | $16,770 | 97.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 270 | $21,241 | $14,056 | 66.2% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 27 | 28 | $3,728 | $2,630 | 70.6% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 27 | 28 | $1,036 | $696.24 | 67.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 224 | $25,874 | $17,088 | 66.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 126 | 126 | $15,874 | $15,646 | 98.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 288 | $22,676 | $14,823 | 65.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 116 | 235 | $27,114 | $19,344 | 71.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 121 | 121 | $15,245 | $15,119 | 99.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 115 | 272 | $21,398 | $14,742 | 68.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 115 | 315 | $24,781 | $16,542 | 66.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 124 | 124 | $15,591 | $15,411 | 98.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 100 | 189 | $21,807 | $14,868 | 68.2% |
About Dr. Robert Schiff, M.D
Dr. Robert Schiff, M.D is a Internal Medicine healthcare provider based in Aiea, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235234378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Schiff, M.D has received a total of $2,810 in payments from pharmaceutical and medical device companies, with $262.16 received in 2024. These payments were reported across 147 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,810).
As a Medicare-enrolled provider, Schiff has provided services to 1,486 Medicare beneficiaries, totaling 2,610 services with total Medicare billing of $196,771. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Aiea, HI
- Active Since 09/13/2006
- Last Updated 03/22/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235234378
Products in Payments
- Vascepa (Drug) $372.10
- Ozempic (Drug) $318.08
- FARXIGA (Drug) $308.68
- Rybelsus (Drug) $127.18
- Victoza (Drug) $121.45
- ENTRESTO (Drug) $116.84
- Otezla (Drug) $110.41
- BYDUREON (Drug) $106.46
- Myrbetriq (Drug) $82.10
- XARELTO (Drug) $79.04
- Saxenda (Drug) $76.14
- TRULICITY (Drug) $67.91
- PRALUENT (Drug) $64.26
- Wegovy (Drug) $62.88
- MOUNJARO (Drug) $60.04
- MYRBETRIQ (Drug) $51.74
- ANORO (Drug) $51.72
- Levemir (Drug) $42.84
- INVOKANA (Drug) $41.37
- Tymlos (Biological) $30.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Aiea
Roy Ebisu, Md, MD
Internal Medicine — Payments: $18,765
Internal Medicine $18,765
Stephen Miyasato, Md, MD
Internal Medicine — Payments: $18,084
Internal Medicine $18,084
Dr. Francis Buto, M.d, M.D
Internal Medicine — Payments: $14,868
Internal Medicine $14,868
Dr. Alan Oki, Md, MD
Internal Medicine — Payments: $14,573
Internal Medicine $14,573
Mark Nishihara, M.d, M.D
Internal Medicine — Payments: $14,206
Internal Medicine $14,206
Dr. Malissa Iida-Takashima, Md, MD
Internal Medicine — Payments: $13,761
Internal Medicine $13,761